First-trimester surgical abortion practices: a survey of National Abortion Federation members

Contraception

Volumn 79, Issue 5, 2009, Pages 385-392

  O'Connell, Katharine ^a   Jones, Heidi E ^a   Simon, Melissa ^b   Saporta, Vicki ^c   Paul, Maureen ^d   Lichtenberg, E Steve ^b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c National Abortion Federation   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Abortion; Canada; Dilation and curettage; First trimester surgical abortion; United States

Indexed keywords

ANTIEMETIC AGENT; ANXIOLYTIC AGENT; COCODAMOL; MEDROXYPROGESTERONE ACETATE; METHYLERGOMETRINE; MISOPROSTOL; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; TRANQUILIZER;

ANESTHESIA; ANTIBIOTIC THERAPY; ARTICLE; AUSTRALIA; CANADA; CLINICAL PRACTICE; CLINICAL PROTOCOL; CURETTAGE; EVIDENCE BASED PRACTICE; FIRST TRIMESTER PREGNANCY; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HUMAN; LEGAL ABORTION; MEDICAL PRACTICE; MEDICAL SOCIETY; MEDICAL SPECIALIST; ORGANIZATION; POSTOPERATIVE CARE; POSTOPERATIVE PAIN; QUESTIONNAIRE; SKILL; SURGICAL ABORTION; UNITED STATES; VACUUM ASPIRATION;

ABORTION, INDUCED; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; MISOPROSTOL; OXYTOCICS; PERIOPERATIVE CARE; PHYSICIANS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREOPERATIVE CARE;

EID: 63049096264     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2008.11.005     Document Type: Article

References (33)

1. Jones R.K., Zolna M.R.S., Henshaw S.K., and Finer L.B. Abortion in the United States: incidence and access to services, 2005. Perspect Sexual Reprod Health 40 (2008) 6-16
2. Strauss L.T., Gamble S.B., Parker W.Y., Cook D.A., Zane S.B., and Hamden S. Abortion surveillance - United States, 2004. MMWR Surveill Summ 56 (2007) 1-33
3. Landy U., and Lewit S. Administrative, counseling and medial practices in National Abortion Federation facilities. Fam Plann Perspect 14 (1982) 257-262
4. Lichtenberg E.S., Paul M., and Jones H. First trimester surgical abortion practices: a survey of National Abortion Federation members. Contraception 64 (2001) 345-352
5. National Abortion Federation. Clinical policy guidelines (2002), National Abortion Federation, Washington, DC
6. O'Connell K., Jones H., Lichtenberg E.S., and Paul M. Second trimester surgical abortion practices: a survey of National Abortion Federation members. Contraception 78 6 (2008) 492-499
7. Finer L.B., and Henshaw S.K. Estimates of US abortion incidence, 2001-2003. Perspect Sexual Reprod Health 35 (2003) 6-15
8. Strauss L.T., Herndon J., Chang J., et al. CDC. Abortion surveillance - United States, 2001. MMWR Surveill Summ 53 (2004) 1-32
9. Statistics Canada, Health Statistics Division. Induced abortions by province and territory of report. CANSIM, table 106-9005 and catalogue no. 82-223-X (2001), Canadian Institute for Health Information, Ottawa (Ontario, Canada). http://www40.statcan.ca/l01/cst01/health40a.htm
10. Grimes D.A. Clinicians who provide abortions: the thinning ranks. Obstet Gynecol 80 (1992) 719-723
11. Eastwood K.L., Kacmar J.E., Steinhauer J., Weitzen S., and Boardman L.A. Abortion training in United States obstetrics and gynecology residency programs. Obstet Gynecol 108 (2006) 303-308
12. Grimes D.A., Schulz K.F., and Cates Jr. W. Prevention of uterine perforation during curettage abortion. JAMA 251 (1984) 2108-2111
13. Lindell G., and Flam F. Management of uterine perforations in connection with legal abortions. Acta Obstet Gynecol Scand 74 (1995) 373-375
14. Hale R.W., Reich L.A., Joiner J.M., Pion R.J., and Kobara T. Histopathologic evaluation of uteri curetted by flexible suction cannula. Am J Obstet Gynecol 125 (1976) 805-808
15. Henry J. Kaiser Family Foundation, and The Picker Institute. From the patient's perspective: quality of abortion care (1999), Kaiser Family Foundation and The Picker Institute, Menlo Park (Calif)
16. Bartlett L.A., Berg C.J., Shulman H.B., et al. Risk factors for legal induced abortion-related mortality in the United States. Obstet Gynecol 103 (2004) 729-737
17. Goldberg A.B., Dean G., Kang M.S., Youssof S., and Darney P.D. Manual versus electric vacuum aspiration for early first-trimester abortion: a controlled study of complication rates. Obstet Gynecol 103 (2004) 101-107
18. Paul M., Mitchell C., Rogers A., Fox M., and Lackie E. Early surgical abortion: efficacy and safety. AJOG 187 (2002) 407-411
19. Creinin M.D., and Edwards J. Early abortion: surgical and medical options. Curr Probl Obstet Gynecol Fertil 20 (1997) 11-19
20. Paul M., Lichtenberg E.S., Borgatta L., Grimes D.A., and Stubblefield P.G. A clinician's guide to medical and surgical abortion (1999), Churchill Livingstone, New York
21. Darney P.D., Atkinson E., and Hirabayashi K. Uterine perforation during second-trimester abortion by cervical dilation and instrumental extraction: a review of 15 cases. Obstet Gynecol 75 (1990) 441-444
22. de Jonge E.T., Jewkes R., Levin J., and Rees H. Randomised controlled trial of the efficacy of misoprostol used as a cervical ripening agent prior to termination of pregnancy in the first trimester. S Afr Med J 90 (2000) 256-262
23. Ngai S.W., Yeung K.C., Lao T., and Ho P.C. Oral misoprostol versus vaginal gemeprost for cervical dilatation prior to vacuum aspiration in women in the sixth to twelfth week of gestation. Contraception 51 (1995) 347-350
24. Hakim-Elahi E., Tovell H.M., and Burnhill M.S. Complications of first-trimester abortion: a report of 170,000 cases. Obstet Gynecol 76 (1990) 129-135
25. Allen R.H., Goldberg A.B., and Board of Society of Family Planning. Cervical dilation before first-trimester surgical abortion (<14 weeks' gestation). SFP guideline 2007. Contraception 76 (2007) 139-156
26. Renton A., Thomas B.M., Gill S., Lowndes C., Taylor-Robinson D., and Patterson K. Chlamydia trachomatis in cervical and vaginal swabs and urine specimens from women undergoing termination of pregnancy. Int J STD AIDS 17 (2006) 443-447
27. Rose S., Lawton B., Brown S., Goodyear-Smith F., and Arroll B. High rates of chlamydia in patients referred for termination of pregnancy: treatment, contact tracing, and implications for screening. N Z Med J 118 (2005) U1348
28. Mallinson H., Hopwood J., Skidmore S., Fenton K., Phillips C., and Jones I. Provision of chlamydia testing in a nationwide service offering termination of pregnancy: with data capture to monitor prevalence of infection. Sex Transm Infect 78 (2002) 416-421
29. Chen S., Li J., and van den Hoek A. Universal screening or prophylactic treatment for Chlamydia trachomatis infection among women seeking induced abortions: which strategy is more cost-effective?. Sex Transm Dis 34 (2007) 230-236
30. Groom T.M., Stewart P., Kruger H., and Bell G. The value of a screen and treat policy for Chlamydia trachomatis in women attending for termination of pregnancy. J Fam Plann Reprod Health Care 27 (2001) 69-72
31. Cameron S.T., and Sutherland S. Universal prophylaxis compared with screen-and-treat for Chlamydia trachomatis prior to termination of pregnancy. BJOG 109 (2002) 606-609
32. Sawaya G.F., Grady D., Kerlikowske K., and Grimes D.A. Antibiotics at the time of induced abortion: the case for universal prophylaxis based on a meta-analysis. Obstet Gynecol 87 (1996) 884-890
33. Paul M., Lackie E., Mitchell C., Rogers A., and Fox M. Is pathology examination useful after early surgical abortion?. Obstet Gynecol 99 (2002) 567-571